Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib with Carboplatin and Paclitaxel in Esophageal and GEJ Adenocarcinoma
NCT01395537Phase 2Terminated
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Aug 2011
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib in esophageal adenocarcinoma (EAC), adenocarcinoma of the gastroesophageal junction, sponsored by Case Comprehensive Cancer Center. Started Aug 2011; status: terminated.
02
Drugs
lapatinib
03
Conditions
esophageal adenocarcinoma (EAC)adenocarcinoma of the gastroesophageal junction
Beyond the preview
Go deeper on NCT01395537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01395537.